Berger Dietmar (CIK 1739515) reported 7 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-11). Recent activity: Buy GILD (533 shares), Sell GILD (263 shares), Buy GILD (2,133 shares), Sell GILD (1,063 shares), Buy GILD (8,530 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-11 | GILEAD SCIENCES, INC. (GILD) | Chief Medical Officer | Buy | 533 | $0 |
| 2026-06-11 | GILEAD SCIENCES, INC. (GILD) | Chief Medical Officer | Sell | 263 | $31,949 |
| 2026-03-12 | GILEAD SCIENCES, INC. (GILD) | Chief Medical Officer | Buy | 2,133 | $0 |
| 2026-03-12 | GILEAD SCIENCES, INC. (GILD) | Chief Medical Officer | Sell | 1,063 | $157,919 |
| 2026-03-02 | GILEAD SCIENCES, INC. (GILD) | Chief Medical Officer | Buy | 8,530 | $0 |
| 2026-01-05 | GILEAD SCIENCES, INC. (GILD) | Chief Medical Officer | Buy | 16,326 | $0 |
| 2026-01-05 | GILEAD SCIENCES, INC. (GILD) | Chief Medical Officer | Sell | 6,944 | $844,390 |
Source: SEC Form 4 filings · as of 2026-06-11